JNM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


The Journal of Nuclear Medicine Vol. 35 No. 2 195-202
© 1994 by Society of Nuclear Medicine
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bautovich, G.
Right arrow Articles by Basten, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bautovich, G.
Right arrow Articles by Basten, A.

Detection of Deep Venous Thrombi and Pulmonary Embolus with Technetium-99m-DD-3B6/22 Anti-fibrin Monoclonal Antibody Fab' Fragment

George Bautovich, Socrates Angelides, Fook-T Lee, Robert Greenough, Peter Bundesen, Peter Murray, Peter Schmidt, Richard Waugh, Jack Harris, Kaye Cameron, Richard M. Lambrecht and Antony Basten

Departments of Nuclear Medicine, Radiology and Surgery, Royal Prince Alfred Hospital, Sydney
Biomedicine and Health Program, Ansto, Menai
AGEN Biomedical Ltd., Brisbane
Centenary Institute of Cancer Medicine and Cell Biology, University of Sydney
Departments of Medicine and Surgery, University of Sydney, Australia

Correspondence: Correspondence to: G. Bautovich, Department of Nuclear Medicine, Royal Prince Alfred Hospital, Camperdown, NSW, Australia 2050.

ABSTRACT

Technetium-99m-labeled anti-fibrin DD-3B6/22 Fab' monoclonal antibody fragments, which specifically target human cross-linked fibrin with high affinity, were evaluated in humans for safety and their capacity to detect deep vein thrombi and pulmonary embolism. Methods: Twenty patients with proven deep-vein thrombosis, documented by contrast venography, or venous duplex scan, were injected with a 600 MBq (0.5mg) dose of antibody. Planar images of the lower limbs were recorded at 0, 2, 6 and 24 hr and chest scintigrams were recorded at 6 and 24 hr. Results: All venography documented thrombus sites, calves, popliteal and femoral, were detected with their radioimmunoconjugate. For the venous duplex scan-proven thrombus sites, all except two calf thrombi in two patients with bilateral disease and other positive sites were detected. Five patients had bilateral deep-vein thrombosis with multiple sites being visualized with the radioimmunoconjugate in the calf, popliteal and femoral regions. One case of pulmonary embolus was also definitively demonstrated. Documented thrombus sites were detected at 2 and 6 hr postinjection. Nineteen patients were on heparin. No adverse reactions to the injected dose were observed and one low titer human anti-mouse antibody response may have occurred. Conclusion: The results indicate that 99mTc-DD-3B6/22 Fab' has potential for noninvasive detection of deep-vein thrombosis and pulmonary embolism.

Key Words: technetium-99m • monoclonal antibodies • human cross-linked fibrin • deep vein thrombi • pulmonary embolism • contrast venography • venous duplex scan




This article has been cited by other articles:


Home page
ANGIOLOGYHome page
M. Ciavolella, R. Tavolaro, M. Di Loreto, F. La Torre, A. Nicolai, O. Schillaci, M. Ierardi, F. Scopinaro, and M. Ciavolella
Immunoscintigraphy of Venous Thrombi: Clinical Effectiveness of a New Antifibrin D-Dimer Monoclonal Antibody
Angiology, February 1, 1999; 50(2): 103 - 109.
[Abstract] [PDF]


Home page
CirculationHome page
V. H. D. Bruyn, S. R. Bergmann, B. A. Keyt, and B. E. Sobel
Visualization of Thrombi in Pulmonary Arteries With Radiolabeled, Enzymatically Inactivated Tissue-Type Plasminogen Activator
Circulation, September 1, 1995; 92(5): 1320 - 1325.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY THE JOURNAL OF NUCLEAR MEDICINE
Copyright © 1994 by the Society of Nuclear Medicine.